Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012 (2012), Article ID 878760, 8 pages
http://dx.doi.org/10.1155/2012/878760
Research Article

Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation

1Division of Endocrinology and Metabolism, Department of Medicine, Eastern Virginia Medical School, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, 855 West Brambleton Avenue, Norfolk, VA 23510, USA
2Inter Science Institute, 944 West Hyde Park Boulevard, Inglewood, CA 90302, USA

Received 19 July 2011; Accepted 7 September 2011

Academic Editor: Nicola Montano

Copyright © 2012 David C. Lieb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Berry, J. C. Tardif, and M. G. Bourassa, “Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management,” Journal of the American College of Cardiology, vol. 49, no. 6, pp. 631–642, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. F. J. Wackers, L. H. Young, S. E. Inzucchi et al., “Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study,” Diabetes Care, vol. 27, no. 8, pp. 1954–1961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. Valensi, R. N. Sachs, B. Harfouche et al., “Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia,” Diabetes Care, vol. 24, no. 2, pp. 339–343, 2001. View at Google Scholar · View at Scopus
  5. A. Katz, I. F. Liberty, A. Porath, I. Ovsyshcher, and E. N. Prystowsky, “A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction,” American Heart Journal, vol. 138, no. 1 I, pp. 32–38, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kempler, S. Tesfaye, N. Chaturvedi et al., “Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM complications study,” Diabetic Medicine, vol. 19, no. 11, pp. 900–909, 2002. View at Publisher · View at Google Scholar
  7. R. Pop-Busui, G. Evans, H. Gerstein et al., “Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial,” Diabetes Care, vol. 33, no. 7, pp. 1578–1584, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. I. Vinik, R. E. Maser, and D. Ziegler, “Neuropathy: the crystal ball for cardiovascular disease?” Diabetes Care, vol. 33, no. 7, pp. 1688–1690, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. A. Bray, M. B. Clearfield, D. J. Fintel, and D. S. Nelinson, “Overweight and obesity: the pathogenesis of cardiometabolic risk,” Clinical Cornerstone, vol. 9, no. 4, pp. 30–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. Maury and S. M. Brichard, “Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome,” Molecular and Cellular Endocrinology, vol. 314, no. 1, pp. 1–16, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. Vinik, R. Maser, and D. Ziegler, “Autonomic imbalance: prophet of doom or scope for hope?” Diabetic Medicine, vol. 28, no. 6, pp. 643–651, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. G. Mamikunian, “Modern laboratory evaluation of peptide and amines: a continuing role for radioimmunoassay?” Endocrinology and Metabolism Clinics of North America, vol. 40, no. 1, pp. 135–151, 2011. View at Publisher · View at Google Scholar · View at PubMed
  14. J. C. Levy, D. R. Matthews, and M. P. Hermans, “Correct homeostasis model assessment (HOMA) evaluation uses the computer program,” Diabetes Care, vol. 21, no. 12, pp. 2191–2192, 1998. View at Google Scholar · View at Scopus
  15. R. Pop-Busui, “Cardiac autonomic neuropathy in diabetes: a clinical perspective,” Diabetes Care, vol. 33, no. 2, pp. 434–441, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology, “Heart rate variability: standards of measurement, physiological interpretation, and clinical use,” Circulation, vol. 93, no. 5, pp. 1043–1065, 1996. View at Google Scholar
  17. G. Sundkvist, A. Lo, and B. Lilja, “Respiratory influence on heart rate in diabetes mellitus,” British Medical Journal, vol. 1, no. 6168, pp. 924–925, 1979. View at Google Scholar · View at Scopus
  18. A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. W. Agelink, R. Malessa, B. Baumann et al., “Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate,” Clinical Autonomic Research, vol. 11, no. 2, pp. 99–108, 2001. View at Google Scholar · View at Scopus
  20. R. Gandhi, J. Marques, D. Selvarajah, C. Emery, and S. Tesfaye, “Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy: an insight into the pathogenesis of pain,” Diabetes Care, vol. 33, no. 7, pp. 1585–1590, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. D. M. Fraser, I. W. Campbell, D. J. Ewing, A. Murray, J. M. Neilson, and B. F. Clarke, “Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus,” Diabetes, vol. 26, no. 6, pp. 546–550, 1977. View at Google Scholar
  22. M. A. Pfeifer, C. R. Weinberg, D. L. Cook, A. Reenan, J. B. Halter, and J. W. Ensinck, “Autonomic neural dysfunction in recently diagnosed diabetic subjects,” Diabetes Care, vol. 7, no. 5, pp. 447–453, 1984. View at Google Scholar
  23. E. A. McDaid, B. Monaghan, A. I. Parker, J. R. Hayes, and J. A. Allen, “Peripheral autonomic impairment in patients newly diagnosed with type II diabetes,” Diabetes Care, vol. 17, no. 12, pp. 1422–1427, 1994. View at Google Scholar · View at Scopus
  24. R. D. Hoeldtke, K. D. Bryner, and K. VanDyke, “Oxidative stress and autonomic nerve function in early type 1 diabetes,” Clinical Autonomic Research, vol. 21, no. 1, pp. 19–28, 2011. View at Google Scholar
  25. R. E. Schmidt, D. A. Dorsey, L. N. Beaudet et al., “A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes,” Experimental Neurology, vol. 192, no. 2, pp. 407–419, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. C. J. Chang, Y. C. Yang, F. H. Lu et al., “Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome,” American Journal of Medicine, vol. 123, no. 5, pp. 432–438, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. H. E. Bays, “"Sick Fat," metabolic disease, and atherosclerosis,” American Journal of Medicine, vol. 122, no. 1, pp. S26–S37, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. P. März, J. G. Cheng, R. A. Gadient et al., “Sympathetic neurons can produce and respond to interleukin 6,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 3251–3256, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. R. P. Sloan, H. McCreath, K. J. Tracey, S. Sidney, K. Liu, and T. Seeman, “RR interval variability is inversely related to inflammatory markers: the CARDIA study,” Molecular Medicine, vol. 13, no. 3-4, pp. 178–184, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. Lampert, J. D. Bremner, S. Su et al., “Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men,” American Heart Journal, vol. 156, no. 4, pp. 759.e1–759.e7, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. Mora, K. Musunuru, and R. S. Blumenthal, “The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines,” Clinical Chemistry, vol. 55, no. 2, pp. 219–228, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. D. C. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma, “Adipokines: molecular links between obesity and atheroslcerosis,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2031–H2041, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. W. G. Haynes, D. A. Morgan, S. A. Walsh, A. L. Mark, and W. I. Sivitz, “Receptor-mediated regional sympathetic nerve activation by leptin,” Journal of Clinical Investigation, vol. 100, no. 2, pp. 270–278, 1997. View at Google Scholar · View at Scopus
  34. G. Paolisso, D. Manzella, N. Montano, A. Gambardella, and M. Varricchio, “Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 5, pp. 1810–1814, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Imai, H. Katagiri, T. Yamada et al., “Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice,” Obesity, vol. 14, no. 7, pp. 1132–1141, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. S. Wakabayashi and Y. Aso, “Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation,” Diabetes Care, vol. 27, no. 10, pp. 2392–2397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Tracey, “Reflex control of immunity,” Nature Reviews Immunology, vol. 9, no. 6, pp. 418–428, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. D. J. van Westerloo, I. A. Giebelen, S. Florquin et al., “The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice,” Gastroenterology, vol. 130, no. 6, pp. 1822–1830, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. T. R. Bernik, S. G. Friedman, M. Ochani et al., “Pharmacological stimulation of the cholinergic antiinflammatory pathway,” Journal of Experimental Medicine, vol. 195, no. 6, pp. 781–788, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. van Maanen, M. C. Lebre, T. van der Poll et al., “Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 114–122, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. K. S. Stein, I. C. McFarlane, N. Goldberg, and E. M. Ginzler, “Heart rate variability in patients with systemic lupus erythematosus,” Lupus, vol. 5, no. 1, pp. 44–48, 1996. View at Google Scholar · View at Scopus
  42. H. Evrengül, D. Dursunoglu, V. Cobankara et al., “Heart rate variability in patients with rheumatoid arthritis,” Rheumatology International, vol. 24, no. 4, pp. 198–202, 2004. View at Google Scholar · View at Scopus
  43. H. Kumar, M. Mishra, S. Bajpai et al., “Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes,” Acta Diabetologica. In press.